CN1663607A - 一种抗衰老的药物 - Google Patents
一种抗衰老的药物 Download PDFInfo
- Publication number
- CN1663607A CN1663607A CN 200410104432 CN200410104432A CN1663607A CN 1663607 A CN1663607 A CN 1663607A CN 200410104432 CN200410104432 CN 200410104432 CN 200410104432 A CN200410104432 A CN 200410104432A CN 1663607 A CN1663607 A CN 1663607A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- chinese medicine
- fructus
- mannatide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 141
- 230000000694 effects Effects 0.000 claims abstract description 40
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229960003987 melatonin Drugs 0.000 claims abstract description 33
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims abstract description 33
- 230000036039 immunity Effects 0.000 claims abstract description 26
- 150000003254 radicals Chemical class 0.000 claims abstract description 25
- 210000000582 semen Anatomy 0.000 claims description 59
- 241000190633 Cordyceps Species 0.000 claims description 26
- 241000208340 Araliaceae Species 0.000 claims description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 24
- 235000008434 ginseng Nutrition 0.000 claims description 24
- 239000009636 Huang Qi Substances 0.000 claims description 23
- 241000756943 Codonopsis Species 0.000 claims description 18
- 241000218628 Ginkgo Species 0.000 claims description 17
- 235000011201 Ginkgo Nutrition 0.000 claims description 17
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 17
- 244000269722 Thea sinensis Species 0.000 claims description 17
- 235000009569 green tea Nutrition 0.000 claims description 17
- 230000002605 anti-dotal effect Effects 0.000 claims description 15
- 210000002826 placenta Anatomy 0.000 claims description 14
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 14
- 241000222336 Ganoderma Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 230000000955 neuroendocrine Effects 0.000 claims description 13
- 230000004060 metabolic process Effects 0.000 claims description 12
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 241000131808 Scolopendra Species 0.000 claims description 9
- 230000001105 regulatory effect Effects 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 230000004083 survival effect Effects 0.000 claims description 8
- 244000293323 Cosmos caudatus Species 0.000 claims description 7
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 7
- 206010064571 Gene mutation Diseases 0.000 claims description 7
- 229940038481 bee pollen Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 abstract description 154
- 238000000034 method Methods 0.000 abstract description 22
- 238000002360 preparation method Methods 0.000 abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 10
- 229920000057 Mannan Polymers 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 5
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 4
- 230000001537 neural effect Effects 0.000 abstract description 2
- 230000001360 synchronised effect Effects 0.000 abstract description 2
- 230000009758 senescence Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 241000699670 Mus sp. Species 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 30
- 239000008280 blood Substances 0.000 description 30
- 210000003743 erythrocyte Anatomy 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- 230000032683 aging Effects 0.000 description 27
- 241001465754 Metazoa Species 0.000 description 25
- 229940079593 drug Drugs 0.000 description 22
- 239000000047 product Substances 0.000 description 21
- 241001494479 Pecora Species 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 16
- 238000000855 fermentation Methods 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 230000004151 fermentation Effects 0.000 description 15
- 108010010998 polyactin A Proteins 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 14
- 230000037396 body weight Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000008363 phosphate buffer Substances 0.000 description 14
- 239000013558 reference substance Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 206010018910 Haemolysis Diseases 0.000 description 10
- 102000019197 Superoxide Dismutase Human genes 0.000 description 10
- 108010012715 Superoxide dismutase Proteins 0.000 description 10
- 230000008588 hemolysis Effects 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 239000000427 antigen Substances 0.000 description 9
- 108091007433 antigens Proteins 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000001541 thymus gland Anatomy 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 240000001341 Reynoutria japonica Species 0.000 description 7
- 235000018167 Reynoutria japonica Nutrition 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 206010070834 Sensitisation Diseases 0.000 description 6
- 230000003005 anti-senility effect Effects 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 238000010241 blood sampling Methods 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 230000005847 immunogenicity Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000002207 metabolite Substances 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000009849 deactivation Effects 0.000 description 5
- 229960004756 ethanol Drugs 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000011218 seed culture Methods 0.000 description 5
- 230000007958 sleep Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000005660 chlorination reaction Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 238000009413 insulation Methods 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 4
- UICBCXONCUFSOI-UHFFFAOYSA-N n'-phenylacetohydrazide Chemical compound CC(=O)NNC1=CC=CC=C1 UICBCXONCUFSOI-UHFFFAOYSA-N 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 210000004279 orbit Anatomy 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000008354 sodium chloride injection Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 230000005778 DNA damage Effects 0.000 description 3
- 231100000277 DNA damage Toxicity 0.000 description 3
- 241000255601 Drosophila melanogaster Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000009189 diving Effects 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000004727 humoral immunity Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002787 reinforcement Effects 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 206010006100 Bradykinesia Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000288673 Chiroptera Species 0.000 description 2
- 108010077544 Chromatin Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000005486 microgravity Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000011020 pilot scale process Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- KVJHGPAAOUGYJX-UHFFFAOYSA-N 1,1,3,3-tetraethoxypropane Chemical compound CCOC(OCC)CC(OCC)OCC KVJHGPAAOUGYJX-UHFFFAOYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000011549 displacement method Methods 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000009605 growth rhythm Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000008458 response to injury Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004101044323A CN100360178C (zh) | 2003-12-31 | 2004-12-19 | 一种抗衰老的药物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310122257 | 2003-12-31 | ||
CN200310122257.6 | 2003-12-31 | ||
CNB2004101044323A CN100360178C (zh) | 2003-12-31 | 2004-12-19 | 一种抗衰老的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1663607A true CN1663607A (zh) | 2005-09-07 |
CN100360178C CN100360178C (zh) | 2008-01-09 |
Family
ID=35035035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004101044323A Expired - Fee Related CN100360178C (zh) | 2003-12-31 | 2004-12-19 | 一种抗衰老的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100360178C (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102068638A (zh) * | 2011-01-03 | 2011-05-25 | 山东大学威海分校 | 一种复方茯苓制剂的制备方法及其用途 |
CN102309002A (zh) * | 2010-07-06 | 2012-01-11 | 何德宝 | 一种能够延年益寿的粥 |
CN101874855B (zh) * | 2009-12-01 | 2012-04-18 | 仝太云 | 一种多味中药制成的治疗不孕不育症胶囊 |
CN102846720A (zh) * | 2012-09-29 | 2013-01-02 | 广西梧州制药(集团)股份有限公司 | 一种降血脂、提高缺氧耐受力的组合物 |
CN102907502A (zh) * | 2012-11-05 | 2013-02-06 | 贵州神奇集团控股有限公司 | 一种虫草保健饮料及其制备方法 |
CN103083514A (zh) * | 2013-01-29 | 2013-05-08 | 胡翔燕 | 一种抗衰老的中药组合物 |
CN103229985A (zh) * | 2013-03-29 | 2013-08-07 | 李月素 | 一种抗衰老鱼头酱的制作方法 |
US8586106B2 (en) | 2011-12-06 | 2013-11-19 | The Concentrate Manufacturing Company Of Ireland | Fatigue-relieving herbal extracts and beverages comprising the same |
CN103875801A (zh) * | 2014-03-21 | 2014-06-25 | 西北大学 | 褪黑素用于果蔬保鲜的应用及保鲜方法 |
CN103976058A (zh) * | 2014-04-25 | 2014-08-13 | 贵州三泓药业股份有限公司 | 一种太子参绿茶饮品 |
CN104055852A (zh) * | 2014-06-30 | 2014-09-24 | 广西中医药大学 | 治疗老年痴呆症的中药组合物及其制备方法 |
CN104208554A (zh) * | 2014-09-19 | 2014-12-17 | 胡康有 | 主治多种女性疾病的中药 |
CN104888183A (zh) * | 2015-06-16 | 2015-09-09 | 郑相国 | 养生保健中成药 |
CN111714565A (zh) * | 2020-07-06 | 2020-09-29 | 戴克渝 | 一种增高用中药配方及其制备方法 |
CN115462524A (zh) * | 2022-08-29 | 2022-12-13 | 杭州佰倍优生物科技有限公司 | 一种具有美容抗衰老作用的血肽及其制备方法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101461918B (zh) * | 2007-12-20 | 2011-02-23 | 汉生堂药业有限公司 | 一种治疗男性更年期综合症及延缓衰老的药物组合物 |
CN101564505B (zh) * | 2008-04-23 | 2010-12-15 | 北京绿源求证科技发展有限责任公司 | 一种治疗肺心病的中药 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1457880A (zh) * | 2003-04-26 | 2003-11-26 | 南昌弘益科技有限公司 | 多抗甲素滴丸及其制备方法——用于免疫机能低下 |
-
2004
- 2004-12-19 CN CNB2004101044323A patent/CN100360178C/zh not_active Expired - Fee Related
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101874855B (zh) * | 2009-12-01 | 2012-04-18 | 仝太云 | 一种多味中药制成的治疗不孕不育症胶囊 |
CN102309002A (zh) * | 2010-07-06 | 2012-01-11 | 何德宝 | 一种能够延年益寿的粥 |
CN102068638A (zh) * | 2011-01-03 | 2011-05-25 | 山东大学威海分校 | 一种复方茯苓制剂的制备方法及其用途 |
US8586106B2 (en) | 2011-12-06 | 2013-11-19 | The Concentrate Manufacturing Company Of Ireland | Fatigue-relieving herbal extracts and beverages comprising the same |
CN102846720B (zh) * | 2012-09-29 | 2013-11-13 | 广西梧州制药(集团)股份有限公司 | 一种降血脂、提高缺氧耐受力的组合物 |
CN102846720A (zh) * | 2012-09-29 | 2013-01-02 | 广西梧州制药(集团)股份有限公司 | 一种降血脂、提高缺氧耐受力的组合物 |
CN102907502A (zh) * | 2012-11-05 | 2013-02-06 | 贵州神奇集团控股有限公司 | 一种虫草保健饮料及其制备方法 |
CN103083514A (zh) * | 2013-01-29 | 2013-05-08 | 胡翔燕 | 一种抗衰老的中药组合物 |
CN103229985A (zh) * | 2013-03-29 | 2013-08-07 | 李月素 | 一种抗衰老鱼头酱的制作方法 |
CN103875801A (zh) * | 2014-03-21 | 2014-06-25 | 西北大学 | 褪黑素用于果蔬保鲜的应用及保鲜方法 |
CN103875801B (zh) * | 2014-03-21 | 2015-08-12 | 西北大学 | 褪黑素用于果蔬保鲜的应用及保鲜方法 |
CN103976058A (zh) * | 2014-04-25 | 2014-08-13 | 贵州三泓药业股份有限公司 | 一种太子参绿茶饮品 |
CN104055852A (zh) * | 2014-06-30 | 2014-09-24 | 广西中医药大学 | 治疗老年痴呆症的中药组合物及其制备方法 |
CN104055852B (zh) * | 2014-06-30 | 2016-04-13 | 广西中医药大学 | 治疗老年痴呆症的中药组合物及其制备方法 |
CN104208554A (zh) * | 2014-09-19 | 2014-12-17 | 胡康有 | 主治多种女性疾病的中药 |
CN104888183A (zh) * | 2015-06-16 | 2015-09-09 | 郑相国 | 养生保健中成药 |
CN111714565A (zh) * | 2020-07-06 | 2020-09-29 | 戴克渝 | 一种增高用中药配方及其制备方法 |
CN115462524A (zh) * | 2022-08-29 | 2022-12-13 | 杭州佰倍优生物科技有限公司 | 一种具有美容抗衰老作用的血肽及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100360178C (zh) | 2008-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1663607A (zh) | 一种抗衰老的药物 | |
CN101068541A (zh) | 应用石榴酸增强免疫应答、防止代谢紊乱的方法 | |
CN1663604A (zh) | 一种治疗慢性咽炎的喷雾剂 | |
CN1141115C (zh) | 一种改善视觉功能的保健品 | |
CN1663597A (zh) | 一种补气养血药物组合物及其制备方法 | |
CN1528783A (zh) | 一种法氏囊素的提取方法及其在疾病治疗和免疫中的应用 | |
CN100341492C (zh) | 一种参芪降糖软胶囊及其制备检测方法 | |
CN1663602A (zh) | 一种治疗神经衰弱的药物 | |
CN1060384C (zh) | 一种抗衰老药物口服液及其制备方法 | |
CN1555729A (zh) | 一种用于营养供给或/和免疫增强的肠内营养制剂 | |
CN1831015A (zh) | 贞芪多糖的提取工艺及其产品和它的应用 | |
CN1535700A (zh) | 一种补血药物组合物 | |
CN1813780A (zh) | 一种用于治疗外感高热和急慢性肝损伤的中药成分组合物及制备方法 | |
CN1335161A (zh) | 全鹿骨粉胶囊 | |
CN1650996A (zh) | 一种药物组合物及其制备方法和应用 | |
CN1237995C (zh) | 能够使异常黑胆质型体液成熟和清除的药物及其制备方法 | |
CN1256081C (zh) | 鸦胆子油乳注射液的制备方法 | |
CN1207030C (zh) | 一种具有抗肿瘤、抗自由基损伤和调节免疫的天然生物反应调节剂 | |
CN1569195A (zh) | 一种圣地红景天软胶囊制剂及其制备方法 | |
CN1190223C (zh) | 一种治疗脓毒症的中药制剂及其制备方法 | |
CN1593482A (zh) | 一种治疗中老年记忆力减退的药物及其制备方法 | |
CN1634496A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN1562144A (zh) | 治疗肠易激综合症的中药组合物及其制备方法 | |
CN1853701A (zh) | 一种洋参生脉药物的有效部位及其制备方法 | |
CN1271945C (zh) | 一种神经节苷脂和豆类食品的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: XI AN HENGTONG GUANGHUA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHAO HENG Effective date: 20080411 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080411 Address after: E building, 17 Yang Road, No. 27, hi tech Zone, Xi'an, Shaanxi Patentee after: Xi'an Hengtong Guanghue Pharmaceutical Co.,Ltd Address before: E building, 17 Yang Road, No. 27, hi tech Zone, Xi'an, Shaanxi Patentee before: Zhao Heng |
|
PP01 | Preservation of patent right |
Effective date of registration: 20081225 Pledge (preservation): Preservation |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20091225 Pledge (preservation): Preservation registration |
|
PP01 | Preservation of patent right |
Effective date of registration: 20100611 Granted publication date: 20080109 |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20101211 Granted publication date: 20080109 |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080109 Termination date: 20101219 |